HeLa cell extracts perform non-replicative DNA synthesis on plasmids methylated with N-methyl-N-nitrosourea (MNU) and containing approximately one O 6 -meG per molecule [1] . Three lines of evidence indicate that this DNA synthesis represents processing of O 6 -meG. First, pretreatment of MNU-treated plasmid with a purified recombinant human O 6 -meG-DNA methyltransferase (MGMT), which selectively removes the methyl group from O 6 -meG in DNA, reduces the extent of this type of DNA synthesis (Fig. 1a and [1] ). Second, active MGMT in extracts of Mex + HeLaS3 cells (Mex + denotes expression of MGMT) decreases the level of DNA synthesis to approximately half that carried out by Mex -HeLaMR extracts, which do not contain detectable MGMT (Fig. 1a  and [3] ). And third, the aberrant DNA synthesis does not occur to a significant extent on a methyl methanesulfonatetreated substrate that contains essentially no O 6 -meG [1].
Results and discussion
HeLa cell extracts perform non-replicative DNA synthesis on plasmids methylated with N-methyl-N-nitrosourea (MNU) and containing approximately one O 6 -meG per molecule [1] . Three lines of evidence indicate that this DNA synthesis represents processing of O 6 -meG. First, pretreatment of MNU-treated plasmid with a purified recombinant human O 6 -meG-DNA methyltransferase (MGMT), which selectively removes the methyl group from O 6 -meG in DNA, reduces the extent of this type of DNA synthesis (Fig. 1a and [1] ). Second, active MGMT in extracts of Mex + HeLaS3 cells (Mex + denotes expression of MGMT) decreases the level of DNA synthesis to approximately half that carried out by Mex -HeLaMR extracts, which do not contain detectable MGMT (Fig. 1a and [3] ). And third, the aberrant DNA synthesis does not occur to a significant extent on a methyl methanesulfonatetreated substrate that contains essentially no O 6 -meG [1] .
To determine whether mismatch correction was involved in processing DNA O 6 -meG, we assayed extracts of the colorectal carcinoma cell lines LoVo (hMSH2 -) [4] , HCT116 (hMLH1 -) [5] and DLD-1 (hMSH6/GTBP -) [6] , which have defined defects in mismatch repair proteins (reviewed in [7] ), for their ability to incorporate labelled dAMP into the MNU-treated substrate. They all carried out significantly less O 6 -meG-dependent DNA synthesis than HeLaS3 cell extracts (Fig. 1a) , although they contained comparable levels of MGMT ( [8] and data not shown). These results suggest that mismatch repair is required to process persistent DNA O 6 -meG. Extracts from SW48 cells, which are defective in hMLH1 [9] and are Mex - [8] , incorporated little labelled dAMP into the methylated substrate compared with mismatch-repair-proficient Mex -SW620 cell extracts (Fig. 1b) . Our observations with Mex + and Mex -cell extracts therefore indicate that aberrant synthesis at O 6 -meG is carried out by the mismatch correction pathway.
Addition of hMutS␣, extensively purified by selective ATP elution from single-stranded DNA cellulose [10] , to extracts of LoVo (hMSH2 -) cells restored their ability to perform O 6 -meG-dependent DNA synthesis. Unsupplemented LoVo cell extracts incorporated less than 0.1 pmole dAMP in the assay; in the presence of ~10 fmole hMutS␣, the extent of incorporation was similar to that carried out by extracts of mismatch-repair-proficient Raji or HeLaS3 cells (Fig. 1c and data not shown) . In contrast, incorporation by SW48 (hMLH1 -) cell extracts was unaffected by hMutS␣. Thus, when the missing hMSH2, in the form of the hMutS␣ heterodimer, is supplied to LoVo cell extracts, they acquire the ability to process O 6 -meG. As hMutS␣ was identified by complementing the mismatch repair defect in LoVo cell extracts [10] , these data provide direct confirmation that the aberrant DNA synthesis at O 6 -meG is carried out by mismatch correction. The inability of hMutS␣ to complement the mismatch correction defect in SW48, is consistent with this interpretation.
Biochemical fractionation studies previously suggested that O 6 -meG-dependent DNA synthesis requires DNA polymerase ␦ or ⑀ [1] . To investigate this further, we measured DNA synthesis in the presence of immunoglobulin G (IgG) purified from a polyclonal rabbit anti-human PCNA antiserum. Preincubation of HeLaMR extracts with increasing concentrations of the antibody progressively inhibited O 6 -meG-dependent DNA synthesis by up to 80 % (Fig. 1d) . The dependence of O 6 -meG-induced DNA synthesis on PCNA indicates that hMSH2-hMLH1-dependent mismatch repair requires DNA polymerase ␦ or ⑀.
Resistance to methylating drugs can arise by loss of DNA mismatch repair, and mismatch-repair-defective cells tolerate O 6 -meG in their DNA [2] . Several independent, methylation-tolerant variants of HeLaMR cells were isolated by repeated exposure to MNNG [11] . Clones 6, 7, 12 and 41 have increased spontaneous mutation rates at microsatellite repeats (>15-fold) and at the hypoxanthine guanine phosphoribosyltransferase locus (4-15-fold; [11] and C. Ciotta, G.A., S.C. and M.B., data not shown). We performed band-shift assays with an oligonucleotide containing a single unpaired guanine to determine if any of the clones were defective in mismatch recognition. Clone 12 extracts did not detectably recognize this substrate (Fig. 2a) or a substrate containing a single G⋅T mispair (data not shown), and resembled the mismatch-bindingdefective RajiF12 [12] in this regard. Clones 6, 7 and 41 could bind to both mismatched substrates and resembled Raji (Fig. 2a ) and the parental HeLaMR cells (data not shown). Mismatch repair was investigated directly in clones 6, 7 and 41 by measuring the ability of extracts to repair a single G⋅T mispair in a circular heteroduplex substrate [13] . Parental HeLaMR extracts corrected the G⋅T mismatch, as judged by the creation of a ClaI-sensitive site in a portion of the products recovered after incubation. We did not detect correction of the mismatch by extracts of clones 6, 7 and 41 (Fig. 2b) . Thus, despite their apparently normal mismatch recognition abilities, clones 6, 7 and 41 are all defective in mismatch repair. This suggests that they might be deficient in a later step of the correction pathway.
Extracts of all the methylation-tolerant clones performed little O 6 -meG-induced DNA synthesis, and in this respect they were indistinguishable from the mismatch correction-defective colorectal carcinoma cell extracts (Fig. 3a) . The mismatch repair defects in the methylation-tolerant cells are associated with a deficiency in O 6 -meG-induced DNA synthesis. Analysis of the 'repair' products on agarose gels indicated that, whereas the lowlevel background radioactivity incorporated by the methylation-tolerant extracts was predominantly (> 70 %) in ligated molecules, ≤ 30 % of the incorporation by the HeLaMR extracts was associated with ligated DNA (Fig.  3b) . The low background incorporation by the tolerant cell extracts probably represents completed excision repair of methylated bases other than O 6 -meG [3] . Thus, there are both qualitative and quantitative differences in O 6 -meG processing by wild-type and tolerant cell extracts. O 6 -meG-induced DNA synthesis is not only more extensive in wild-type compared with tolerant cell extracts, but is also associated with DNA repair events that remain incomplete. Restoration of O 6 -meG-induced DNA synthesis by in vitro complementation was used to diagnose the molecular defects in mismatch correction in the tolerant clones. When extracts of clones 6, 7 or 41 were combined pairwise, there was no detectable increase in O 6 -meG-dependent DNA synthesis, suggesting that they might share a common defect. The ability to perform this DNA synthesis was restored to extracts of clone 6, 7 and 41 by adding extracts from DLD-1 (hMSH6/GTBP -) cells. Complementation was essentially complete and the extent of dAMP incorporation by the combined extracts was comparable to that of HeLaS3 extracts. In contrast, no complementation was observed when extracts of the tolerant clones were combined with extracts of HCT116 (hMLH1 -) cells.
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HCT116 cell extracts were, however, able to complement the defect in O 6 -meG-dependent synthesis in DLD-1 extracts (Fig. 3c) . Clones 6, 7 and 41 therefore belong to the same complementation group for O 6 -meGdependent synthesis as the colorectal cell line HCT116, indicating that the mismatch-repair defect in these clones is in hMLH1.
The occurrence of O 6 -meG-related DNA synthesis indicates that the methylated base can be processed by extracts of human cells [1, 3] . The use of colorectal carcinoma cell lines with known defects in mismatch repair now provides direct evidence that O 6 -meG processing occurs by mismatch correction. This processing requires (c) O 6 -meG-dependent DNA synthesis was measured in extracts (100 g) of the methylation-tolerant clones 6, 7 and 41 and the colorectal carcinoma cell lines HCT116 and DLD-1, either alone or in the pairwise combinations shown (100 g each). MexHeLaMR and Mex + HeLaS3 extracts (100 g) were used as controls. In (a,c), incorporation of radioactive dAMP into DE81-adsorbed material was determined as described in [1] . PCNA, indicating that the hMSH2-hMLH1 mismatch repair pathway involves DNA polymerase ␦ and/or ⑀.
O 6 -meG apparently requires the intervention of mismatch repair to convert it into a lethal lesion, and tolerance to DNA methylation damage arises by loss of mismatch repair [12, [14] [15] [16] . The mechanism by which mismatch correction promotes O 6 -meG lethality has remained undefined. The reduced level of O 6 -meG-related DNA synthesis by extracts of both mismatch-repair-defective and methylation-tolerant cell lines suggests that the DNA synthesis reflects lethal processing of the methylated base. Considerable evidence indicates that, despite their resistance to its lethal effects, O 6 -meG remains in the DNA of tolerant cells [17] . This has led to the proposal that mismatch repair is engaged non-productively, that it is incorrectly targeted to the complementary strand and so does not remove O 6 -meG from DNA [2] . This is consistent with our observation of O 6 -meG-dependent synthesis by extracts of normal, but not mismatch-repair-defective tolerant, cells. It is also in agreement with the finding that most of the O 6 -meGdependent synthesis by normal cell extracts is associated with incompletely repaired plasmids.
The mismatch repair deficiencies in methylation-tolerant cells are the same as those found in both familial and sporadic colorectal cancers. Selection for the methylationtolerant phenotype provides a ready source of repairdefective cell lines, and the use of the O 6 -meG-processing assay provides a new approach to elucidate the steps of human mismatch repair.
Materials and methods

Cell lines and culture
HeLaS3, HeLaMR and tolerant variants were grown in DMEM (GIBCO) containing 10 % fetal bovine serum (FBS); Raji and RajiF12 cells were grown in RPMI containing 10 % FBS. Colorectal carcinoma cells (from C. Dixon) were grown in ␣-MEM containing 15 % calf serum.
Preparation of the substrate
Plasmid pKSoriSV, which contains the HindIII-SalI fragment of pSVori, including the SV40 origin of replication, in pBluescript, was methylated with 0.48 mM MNU for 30 min at 37°C in TE (pH 7.5). Methylated bases were quantitated as previously described [1] .
Cell extracts, in vitro O 6 -meG-dependent synthesis and antihuman PCNA antibodies
Cell extracts were prepared and assays were carried out as described [1] . O 6 -meG-dependent synthesis was calculated by subtracting incorporation into the unmodified plasmid (typically around 20 % of the MNU-treated value) from that into the MNU-treated substrate. An IgG fraction from a polyclonal rabbit anti-human PCNA antiserum was obtained from D.P. Lane.
Partial purification of hMutS␣ mismatch binding complex
hMutS␣ was purified from Raji cells essentially as described [10] , omitting the final MonoQ step. The preparation contained two prominent Coomassie Blue-staining bands of 100 and 160 kDa which comprised >50 % of the proteins present.
Binding assay
Preparation of cell extracts and binding to mismatched duplexes was carried out as described [12] . The labeled substrate was either a 39mer containing a single unpaired guanine or a 34mer containing a single G . T mismatch [12] .
Heteroduplex construction and in vitro mismatch repair
Bacteriophage M13 constructs (HK7) were obtained from P. Brooks. Duplex circular molecules containing a nick and a G . T mispair were prepared essentially as described [13] . Assays (20 l) containing 70 g cell extract were carried out as described in [18] . Purified DNA was linearized with AlwNI and incubated with ClaI. Digested products were separated on 1 % agarose and visualized by autoradiography following Southern transfer.
